Lost In Bureaucracy? Novartis Gleevec IP Case Held Up By Indian Legal System
This article was originally published in The Pink Sheet Daily
Executive Summary
Patent case for new form of imatinib will now be reviewed by newly formed Intellectual Property Appellate Board.